drugset / Trial / NCT06867302

Dexmedetomidine and Agitation After Nasal Surgery

NCT06867302 ↗

Recruiting 50 enrolled Fayoum University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The main objective of study is to compare dexmedetomidine single bolus dose before extubation with continuous infusion as regards their efficacy in mitigating the incidence of emergence agitation in obese adults undergoing nasal surgery.

Timeline

Start
2025-03-01
Primary completion
2025-09-01
Completion
2025-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications